Ipsen Pursues Its Development in the United States With the Opening of Its New Commercial Headquarters in New Jersey (NJ)
4/25/2012 10:22:26 AM
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced the official opening of its new commercial headquarters in Basking Ridge, New Jersey. This is an important step forward for Ipsen in the United States, after the significant investment in its Massachusetts-based facility focused on R&D and technical operations (notably bioproduction) and the recently announced completion of its US Leadership Team for commercial operations. This announcement confirms Ipsen’s commitment to growth for its uniquely targeted neurology and endocrinology therapeutics in the United States and to provide innovative specialty medicines to US patients.